Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer products, and other health care products. The company is headquartered in Tokyo, Japan.
| Revenue (TTM) | $4.51T |
| Gross Profit (TTM) | $2.93T |
| EBITDA | $1.35T |
| Operating Margin | 3.09% |
| Return on Equity | 2.61% |
| Return on Assets | 2.63% |
| Revenue/Share (TTM) | $1430.33 |
| Book Value | $15.16 |
| Price-to-Book | 1.05 |
| Price-to-Sales (TTM) | 0.01 |
| EV/Revenue | 2.733 |
| EV/EBITDA | 9.20 |
| Quarterly Earnings Growth (YoY) | 330.20% |
| Quarterly Revenue Growth (YoY) | 3.90% |
| Shares Outstanding | $3.16B |
| Float | $1.58B |
| % Insiders | 0.02% |
| % Institutions | 3.15% |
Volatility is currently contracting